Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-α receptor for drug discovery and mechanism of action (MOA) research

Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-α receptor is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Tanfanercept (HBM9036) is a modified 19 kDa TNF receptor 1 fragment. It is used to relief the signs and symptoms of dry eye disease (DED) and with good eye permeability, strong TNF-α neutralizing activity, high stability, and minor side effects.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-1007-1mg	1mg	3090
GMP-Bios-INN-1007-10mg	10mg	Inquiry
GMP-Bios-INN-1007-100mg	100mg	Inquiry
GMP-Bios-INN-1007-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-α receptor
INN Name	Tanfanercept
Target	TNF-α receptor
Format	Recombinant Protein
Derivation	human
Species Reactivity	human
CH1 Isotype	TBP-1 ( tumor necrosis factor (TNF) binding protein variant 1)
VD LC	TBP-1 ( tumor necrosis factor (TNF) binding protein variant 1)
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	HanAll BioPharma (Seoul South Korea)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0